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Abstract 39 
Introduction  40 
Glaucoma is a lifelong condition often requiring surgical intervention. To allow us to inform 41 
patients expectations of surgery effectively it is important to understand patients’ 42 
preferences and concerns regarding outcomes from glaucoma treatments including surgery.  43 
Aims  44 
To explore what clinical and social outcomes of glaucoma surgery are important to patients.  45 
Methods  46 
Forty-five glaucoma patients undergoing medical glaucoma treatments or surgery were 47 
recruited for focus groups interviews to determine their opinions regarding the outcomes of 48 
glaucoma treatments. Thematic analysis was performed with NVIVO software.  49 
Results 50 
Themes identified were: understanding glaucoma, understanding surgery treatments and 51 
understanding treatment outcomes. The most important outcomes of the glaucoma surgery 52 
reported by the patients were social factors. Patients felt that being able to maintain their 53 
driving licence is a strong indicator of successful glaucoma treatment/surgery. Other 54 
important outcomes were independent living, ability to care for their family and have a quality 55 
of social life.  56 
When considering the novel surgical treatments most patients felt that certainty of successful 57 
outcome and proven longevity of the effect would be the primary motivator for choosing 58 
these treatments. 59 
Conclusions 60 
Patients understood that the clinical measures were surrogates for maintaining visual 61 
function but maintaining quality of life (QOL) for independent living was the most important 62 
outcome from their treatment. For newer treatment patients wished to know more about 63 
long term outcomes when considering this option.  64 
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Background 65 
Glaucoma is a pressure related optic neuropathy affecting 1-2% of population over 40 years 66 
of age and is the second commonest cause for visual impairment registration in the over 65 67 
years age group [1, 2]. Untreated glaucoma is a progressive condition [3] which may severely 68 
impact on quality of life. It is a significant cause of falls [4]; road traffic accidents [4]; loss of 69 
driving licence [5]  loss of independence [4, 6-9] and may lead to blindness [2]. 70 
Lowering the intraocular pressure (IOP) is the only known modifiable risk factor for glaucoma 71 
[3, 10, 11]. IOP reduction can be achieved with medical, laser treatments or surgery [12]. The 72 
criteria for clinical success of the treatment is reduction of IOP which is associated with visual 73 
acuity retention and stabilisation of visual field progression. However, patients’ 74 
understanding, and perception of glaucoma treatment especially surgical treatments 75 
outcomes is unknown. It remains unclear whether these clinical assessments translate into 76 
improvements recognised and valued by patients. It is also unclear how patients conceive the 77 
relative merits of IOP reduction, retention of visual acuity, stabilisation of visual field 78 
progression, or whether they might consider lifestyle influences of the treatment to be more 79 
important. 80 
Prior work has shown that patients demonstrate a varied level of understanding about 81 
glaucoma, its causes and treatments, it also highlights that medical and surgical treatments 82 
are considered quite differently by some patients [13]. Although both treatments are 83 
effective in controlling glaucoma [3, 11, 14, 15] some patients regard surgery more 84 
skeptically, as a treatment of last resort as it is associated with greater risk of side effects and 85 
more severe consequences if complications occur (e.g. blindness) [13]. Consequently, it might 86 
be assumed that patients may expect more from surgical treatment, to counter-balance the 87 
perception of greater risks and they will accept more moderate improvements from medical 88 
treatments; or that they might point to different types of benefits associated with different 89 
types of treatment (surgery to save sight, medical to maintain lifestyle).   90 
In recognition of the importance of patient centered outcomes some large clinical trials have 91 
used quality of life as their primary outcome measures  [16, 17]. 92 
Consequently, there is a need to explore patients’ perspectives, hopes, concerns and 93 
expectations on the outcomes of glaucoma treatment especially surgical treatment. A better 94 
understanding of these will improve patient counselling, by providing clearer and more 95 
explicit patient defined success criteria which might inform the appropriateness of the 96 
medical and surgical options available for glaucoma management in terms important to 97 
patients. 98 
This study will address a lack of information about patients’ notions of glaucoma surgery 99 
outcomes and will explore if patients express different preferences and expectations of 100 
medical and surgical treatment outcomes. The unique insight of patients’ perspectives and 101 
treatment expectations will complement the clinical potential of medical and surgical 102 
glaucoma treatments.103 
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Methods 104 
Ethics approval for this study was obtained from the REC West Midlands, (REC reference 105 
number: 16/WM/0172). Patients attending the glaucoma service at Nottingham University 106 
Hospital were invited to participate in the study.  Participant consent was obtained in 107 
accordance with the REC guidance, and Good Clinical Practice (GCP). 108 
Study Procedures:  109 
The focus group sessions were conducted by two researchers (BK and PL). A semi-structured 110 
topic outline based on the COREQ checklist was used to guide the discussions (Figure 1). The 111 
topic guide was structured to navigate through experience of glaucoma, treatment outcomes, 112 
defining success to encourage discussion amongst the participants guided by the 113 
facilitators[18, 19].   114 
All discussions were digitally recorded, transcribed in full and handled using the NVivo 115 
software package (NVivo qualitative data analysis Software; QSR International Pty Ltd. 116 
Version 11, 2015). Data was analysed following the conventions of thematic analysis and 117 
consisted of data familiarisation, data coding and generation of over-arching themes. The 118 
endpoint of data collection was considered to have been reached when similar themes and 119 
subthemes continued to emerge in the latter focus groups hence it was regarded that ‘data 120 
saturation’ was achieved. 121 
Results 122 
Demographics 123 
45 participants with glaucoma were recruited in this study and organised into seven focus 124 
groups of which 3 groups comprised of patients on medical treatments only and patients in 125 
the remaining four groups had undergone surgical treatments. On average there were 6 126 
patients in each group, females slightly outnumbered male patients in ratio of 1.3:1. The 127 
patients’ age ranged from 52-90 years, all of these patients were residents of East Midlands. 128 
3/4th of the total number of participants were married or in civil partnership at the time of 129 
study (Table 1).130 
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Table 1 Demographic chart of the focus group participants  131 
Focus group No of patients  Age range M:F ratio Marital status Ethnicity 
ST1 7 60-79 1:6 3 married All British 
ST2 2 68, 80 1:1 1 married All British 
ST3 9 61-86 3:6 5 married 5 British 
2 Caribbean 
2 Unknown  
ST4 11 52-87 4:7 9 married  
MT1 5 66-82 2:3 4 married 
1 unknown 
5 British 
MT2 4 71-88 3:1 3 married 
1 widow 
4 British  
MT3 7 69-90 5:2 6 married 
1 unknown 
7 British 
 132 
Legend - Demographics of patients in focus groups 133 
 134 
Abbreviations: MT Medical treated for glaucoma, ST Glaucoma surgery group 135 
Thematic evaluation 136 
Initial coding recognised 781 data points which were grouped into 24 distinct codes (concepts 137 
or ideas). These codes were broadly classified in 3 thematic areas (Figure 2). The hierarchical 138 
organisation of the thematic map, with understanding outcomes considered as a result of a 139 
culmination of participants’ understanding of glaucoma, treatment and outcomes highlights 140 
that the attitudes about treatment outcomes are not detached from but informed by how 141 
the participants understand glaucoma and its management. leading to realistic expectations 142 
about their treatment outcomes.   143 
Understanding Glaucoma  144 
At the beginning of the focus group meetings the patients were asked to discuss their 145 
glaucoma condition and its impact on their lives. This part of the discussion was grouped into 146 
theme of “understanding glaucoma “.  The patients in medical treatment group had glaucoma 147 
from 1-10 years in duration and were on a variety of antiglaucoma eye drops. Most patients 148 
in the medical treatment group had not noted any problems with vision at the time of 149 
diagnosis.  Some patients had noted gradual deterioration of vision over a period due to 150 
progression of glaucoma or worsening of cataracts or both. In the surgery group patients had 151 
glaucoma for longer duration of (approx. 30 years). Initially they were treated with glaucoma 152 
eye drops before having glaucoma surgery.  153 
The diagnosis of glaucoma had generated anxiety in both the group of patients about losing 154 
vision sufficiently to affect their driving, reading, watching television and maintaining 155 
independent life styles.   156 
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For most patient work was not an issue as most of them were retired. “That’s gone out of my 157 
life style all together”. Patients demonstrated good understanding of differences between 158 
visual acuity and visual fields and if given a choice they would consider retaining either of 159 
these visual functions depending on their lifestyles. “I suppose it will depend on a person’s 160 
expectations in their lifestyle and someone who is a hermit and does lots of sewing and 161 
embroidery will probably go for acuity”.  162 
Understanding Treatments 163 
Most of the patients were satisfied with their treatments and glaucoma control. Few patients 164 
had noted that their glaucoma was not well controlled with eye drops only, and few 165 
anticipated further surgical treatment. Glaucoma patients in the medically treated group 166 
described their experience of treatment with regard to effect of eye drops on their lifestyle, 167 
compliance with treatment, IOP control and side-effects of the treatment. Patients in both 168 
groups  expressed their preference to be on antiglaucoma eye drops for as long as possible in 169 
order to avoid surgery. Even those already exposed to surgery expressed these sentiments:   170 
“If I’d had the choice, I would have stayed on the drops rather than have surgery I must 171 
admit …”; “ when you come to the end of the line with the medications, as I have done now 172 
because nothing’s working any more, you can have an operation and that’s a sort of last 173 
resort and that seems to be quite successful”.  As did those who had not had surgery: “Well 174 
from beginning I think I would prefer drops rather than surgery as its easier and not invasive”.  175 
Patients in the surgery group mentioned that they did not notice any improvement in vision 176 
following surgery and still need to use glasses, although this was not a surprise to them, 177 
“Surgery can’t make it  (vision) better, he’s (consultant) always explained that”.  178 
Expectations of glaucoma surgery 179 
There were approximately 21 responses from patients in medical group on their expectations 180 
from glaucoma surgery and 43 comments from patients in surgery group. In the glaucoma 181 
surgery group this subtheme included preoperative perception of glaucoma surgery, 182 
operative and postoperative experience, expectations from glaucoma surgery and number of 183 
glaucoma surgeries. On the other hand, patients in the medical treatment group had variable 184 
information on glaucoma surgeries. Many patients would rely on the decision of the 185 
consultants regarding glaucoma surgery. “And I thought no issues I’m happy to go with it, I 186 
said right, fine, I’ll have an op”. 187 
The patients in both groups had expressed anxiety to have surgery the most important reason 188 
being losing the eye sight and there were no guarantees that the procedure (trabeculectomy) 189 
would work and for how long would it remain effective. “Well the only concern I’ve got is 190 
about the operation is a trial and error process, you know, sort of, cutting some slots in your 191 
eyes and then you go in every day and he sews a bit up more up if the pressures are not 192 
quite right”. 193 
Patients were interested to know the competency of the surgeon going to perform the 194 
surgery before they came for the surgery as patients felt that the success rate of the surgery 195 
depended on the surgeon’s experience. Patients didn’t mind having a new procedure if it had 196 
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high success rate and long-term effects. The concept of successful surgery varied among the 197 
participants, some felt it should improve sight, some felt it should stop the condition getting 198 
worse, some wanted to protect the ability to drive, or the ability to drive at night, or just 199 
walking independently. Participants were quick to suggest that success might mean different 200 
things to different people, and that success means “maintaining your life style in the way 201 
you want”. They hoped this would reduce the number of eye drops they were taking. 202 
In the surgery group, patients had described concerns regarding longevity of the surgery, 203 
aware that scarring could cause failure of the procedure: “I mean trab is supposedly 90% 204 
effective at start and then over 10 years it goes down to 60% because your eye changes and 205 
heals, well 10 years is considered good outcome but not to someone who is young, it’s not 206 
very long”.  Building on this another participant indicated that “I think for the individual you’d 207 
think about how long am I likely to live so that’s going to impact into that decision isn’t it”? 208 
The main initiative for opting for surgery in both groups was the expectation that the surgery 209 
would stabilise their condition by restricting the visual field loss, reduce or stop the use of the 210 
eye drops possibly lifelong hence avoiding or minimising their side effects and reduce the 211 
amount of follow ups required to once or twice a year. 212 
Understanding Outcomes 213 
Consideration of treatment outcomes showed a complex and multi-faceted reasoning process 214 
where participants drew together factors which might be viewed as clinical (IOP), alongside 215 
more general concerns (expectations of surgery and lifestyle), and more specific issues (such 216 
as driving and follow-up procedures). 217 
Few study participants did not appreciate the significance of IOP control, although most 218 
considered IOP reduction as an important outcome of any glaucoma treatment. However, 219 
many noted that the reduction of IOP was not in its own right a meaningful treatment 220 
outcome but was broadly conceived as a requirement or mediator for maintaining sight (table 221 
2, row A, especially (i)). 222 
More than this though maintaining sight was considered key to maintaining normality and 223 
being able to live independently (table 2, row B), pursuing the sorts of activities that they 224 
want to do: 225 
“[treatment] Success means maintaining your lifestyle in the way you want” 226 
Driving was a commonly used example of independent living, but again, even here, driving 227 
might be considered a proxy from some other bigger idea about lifestyle and independence: 228 
 “It not the process of driving per se, it’s the fact that driving allows you to lead an 229 
independent life”  230 
Driving was viewed in different context by the participants, those who were either married or 231 
were with partners especially those who cared for their spouses were more concerned to 232 
keep their driving licences, “Depends entirely on your age and lifestyle to me driving and 233 
getting about is very important … My wife is disabled”. On the contrary some participants 234 
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were not keen on driving as their spouse drove them or they were not driving at all, “I 235 
wouldn’t be bothered to drive, my husband is good, he drops me off…”. 236 
Consideration of visual acuity and visual field as important treatment outcomes offered 237 
complex and nuanced perspectives, with personal circumstances, and the type of lifestyle and 238 
activities desired, again informing a preference for one over the other (table 1, Row C). Hence 239 
it is the personal circumstances which dictate what outcomes a participant desires, rather 240 
than some abstract assessment of the relative merits of the different outcomes. Discussion 241 
of visual acuity and field did however expose more fundamental concerns about sight loss 242 
(table 2, Row D). 243 
Reduction of the burden associated with regularly administering eye drops was considered a 244 
positive outcome of surgical treatment, although this needs to be weighed against several 245 
uncertainties of the surgery: 246 
“It is the scarring that’s the problem isn’t it, it works and then the scarring builds up 247 
so you have it taken away and then, you know, a few months  later or probably a 248 
year later or so, its built up again the scar tissue”. 249 
It is notable that in discussion of treatment development, and about new surgical procedures, 250 
certainty of outcome was identified as an important and appealing potential. Some 251 
participants argued that certainty of outcome was more important to them than scope and 252 
scale of outcome, and that they would accept less improvement if that improvement was 253 
guaranteed rather than uncertain. 254 
‘A successful surgical outcome is either having an improvement of the existing 255 
condition or a sort of guarantee that it would stop the condition getting worse,”  256 
It is pertinent to reflect that in these discussions’ participants reported a range of other 257 
factors (beyond treatment outcome) such as, the nature of the procedure (how long, how 258 
unpleasant), the duration of treatment effect, how well established a procedure is, known 259 
risks and side-effects. These factors might inform the patients’ preference for any surgical 260 
outcome and hence, the surgical procedure itself.  261 
Participant 1: “To be realistic as the glaucoma surgery is done under local 262 
anaesthesia rather than general and you are conscious, so speed is an important 263 
part, 10 minutes procedure under local anaesthesia is good and half an hour is bad”.  264 
Participant 2: “I think, at the end of the day I wouldn’t mind how long the surgery 265 
was as long as you get best results from it”.  266 
Participant 3: “I would prefer unconscious painless surgery any time for procedure 267 
longer than 15 minutes”. 268 
Patients were willing to undergo surgery with increased risk if their eye sight was not good, 269 
“well if my eye sight was really bad, I’d take a big risk, if it was not too bad I wouldn’t want 270 
a big risk”.   271 
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Stable patients with a successful surgery were keen to have follow-ups at least once a year to 272 
ensure that the treatment is working. Most patients gave importance to keeping their follow-273 
up irrespective of frequency and duration of the follow up visits. However, they all preferred 274 
to know their review dates in advance, so they can plan accordingly.  275 
Willingness to try new treatments 276 
Patients expressed a willingness to try newer surgical treatments especially if it was suggested 277 
as beneficial by the clinicians. The idea of new treatments was seemingly attractive:  “Could 278 
we be kept up to date with any innovations, I mean I come on the internet and I flash my 279 
bit of paper at the consultant and then he tells me it doesn’t apply to me, but not everybody 280 
does, I mean it would be nice to know if there is something in the pipe line”; “I think stent is 281 
a better one because its newer, its not going to be long to do, the drops don’t really come 282 
into it. And if you don’t have to come in too often, it’s a bonus.” To consider these newer 283 
treatments, patients were keen to know the duration of the effect of surgery and amount of 284 
aftercare needed. Patients were interested to know if the surgery would be performed under 285 
local or general anaesthesia, duration of the surgical procedure and recovery time were also 286 
important aspect in choosing new surgical treatment. Patients showed preference for 287 
surgeries with long lasting effects and repeatable if not definitive and final treatment.    288 
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Table 2: Patients quotations regarding their views on different aspects of glaucoma 289 
treatment outcomes 290 
 Understandi
ng treatment 
outcomes – 
subthemes. 
Indicative data. 
A Intraocular 
pressures 
i. I don’t feel the glaucoma’s affected my eyes at all. Although every time I come to the 
hospital they say my pressure is high, we will put you on another drop … [Q. is pressure 
an important outcome?] … Yes, but [only because] the pressure needs to be down to 
protect the vision. 
ii. Thank fully you know the pressure seems to be controlled and therefore you know that’s 
never been an issue 
iii. Lowering of intraocular pressure is important to protect vision  
iv. Pressure reassures you that everything’s’ working  
B Preserving 
lifestyle/nor
mality. 
i. I want my life to be the same… I am quite an active person, so you know, I go to the gym 
and I go skiing. I do lots of things and I am concerned that I won’t be able to do some of 
these things.  
ii. I really want my life to be same because you know, it makes me just feel old I have to be 
careful going down and standing up and can’t hoover.  
iii. My leisure and driving come in because I play golf and without the driving I can’t go and 
play golf  
iv. I like to go long distance walking, I don’t want to have to do that with a stick. You know, 
I like to enjoy my walks.  
v. It certainly interfered with my lifestyle having to put those drops in, it sounds pathetic 
vi. I have quite a few eyedrops and carry them with me, just thought, “God, Am I going to 
be trapped in the house doing these eye drops? It felt overwhelming.  
C Field or 
Acuity? 
(Preserving 
lifestyle/nor
mality) 
 
i. I mean I am annoyed that I can’t focus on things. I do lot of DIY and trying to put a little 
screw in somewhere I can’t see annoys me, but I’d sooner have the broad vision than that 
because I can always get the magnifying glass out or put a very strong light on. 
ii. Choosing option of good visual field or visual acuity depends on what is more important to 
maintain your lifestyle of reading, driving, doing the things you are normally doing. 
iii. I suppose it depends on a person’s expectations in their lifestyle and someone who is a 
hermit and does lot of sewing and embroidery will probably go for acuity. 
iv. Again, you would come back to the effect on lifestyle and is field vision more important to 
maintain your lifestyle of reading, driving, doing the things you’re normally doing or is 
acuity going to be better? 
D Preserving 
vision 
I. I’d like a guarantee that I’m not going to go blind before I die. 
II. Basically, just ask me what I would like in my little life is I’d like to save my sight as much 
as possible in order to continue with my lifestyle 
III. So long as the sight is saved it is a sign of success we all agree. 
IV. Yeah, I don’t want my life to get any better, I don’t mind, it can deteriorate a bit but the 
thought of losing my vision  
V. Saving the vision protects your lifestyle, as well doesn’t it? 
VI. Keeping your sight is basically the most important thing. 
  291 
 11 
Discussion 292 
This is the first focus group study to evaluate patients’ perception or understanding of 293 
glaucoma surgery outcomes. Previous studies to determine impact of glaucoma on patients’ 294 
lifestyle have relied on questionnaires and surveys [20-23]. The disadvantages of these 295 
methods are the lack of opportunity for the patients to elaborate their thoughts.  296 
A concern for maintaining functional abilities and independent living influenced the 297 
treatment outcomes expectations, especially the sight focussed outcomes. Stable vision and 298 
visual fields were considered important and first preferred outcomes of successful surgery by 299 
the patients to achieve desired lifestyle, consequently a consideration of individual lifestyle 300 
requirements in treatment planning was appreciated by the patients. Green et al have noted 301 
that self-referrals by patients in the early stages of glaucoma is challenging aspect as patients 302 
naturally adapt to their gradually diminishing vision till they can’t cope any more by this time 303 
the disease would have progressed to moderate to advanced stages, hence early diagnosis 304 
and treatment becomes crucial for effective management[24]. 305 
Therefore, customising the patients’ treatments to suit their lifestyle requirements would 306 
have positive impact on patients’ perceptions of glaucoma treatment outcomes.  307 
IOP (in its own right) was not considered an important outcome by the patients as most of 308 
the patients failed to appreciate fluctuations or changes to their IOP due to their treatments. 309 
Rather stable IOP was recognised as a mediator of stable vision, which was considered an 310 
important outcome. The patient’s expectations of the surgical treatment were that it should 311 
halt the deterioration of glaucoma and on-going treatment with the eye drops.  312 
A number of important themes that  emerged from our study gave  an insight into the clinic 313 
visits and regarding visual field testing from the patient's perspective which could help to 314 
inform patient-centred care in glaucoma.  Although patients appeared frustrated by a number 315 
of aspects of their follow-up, they ultimately accepted that some compromises had to be 316 
made in order to save their eyesight [19] [20]. Some of the viewpoints illustrated in the focus 317 
group discussions may in part explain why research-supported guidelines about more 318 
frequent VF testing are not being implemented effectively in clinical practice. A holistic 319 
approach that embraces patients' opinions may therefore be vital to help devise the most 320 
effective strategies for follow-up care in this chronic disease [25]. 321 
Differences in the themes of discussion between the medically and surgically treated focus 322 
groups were mainly noted in the categories of understanding glaucoma and understanding 323 
treatments. In the surgically treated groups, the patients discussed topics such as their 324 
experience of glaucoma surgery and postoperative recovery of which they had personal 325 
experience. Patients on glaucoma eye drops generally had limited knowledge of glaucoma 326 
surgery and these patients discussed the importance of good IOP control to stabilise the visual 327 
fields.   328 
In both the groups especially in the medical treatment group surgical treatment was 329 
considered a ‘last resort’ and would consider it only when other treatment options were 330 
exhausted. Increased anxiety regarding surgical treatment was felt by patients in medical 331 
group compared to patients in surgical group who were going to have a repeat procedure. 332 
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This was due to risk of going blind from complications of surgery weighed heavily on 333 
patients in medical treatment group compared to patients who had previously undergone 334 
surgical treatment successfully this experience had increased their confidence in the safety 335 
of the current glaucoma surgical treatments. Patients in both groups had expressed similar 336 
opinions regarding expectations from surgical treatment of glaucoma which were mainly 337 
maintaining vision, able to maintain their driving licence and independent living and have a 338 
meaningful social life. Most of the patients considered blindness as the most important 339 
negative consequence of glaucoma surgery and avoiding this risk for as long as possible was 340 
preferable. While it is important to acknowledge that surgery is associated with risks, the 341 
risk of blindness from modern glaucoma surgery is small [26]. Similarly, medical treatments 342 
are not without potential complications and side effects, and may affect surgical success 343 
at a later stage [27].  Discussion of surgery at an early stage of treatment may help to 344 
overcome the misconception that surgery is a treatment of last resort. However, the time 345 
constraints of clinical practice may make implementation of this practice difficult as this 346 
discussion to explore surgery risks and benefits would require additional consultation time. 347 
It was noted that different treatments did not result in differences in the expectations of 348 
the outcomes, i.e. patients did not want greater gains from surgery (to counteract 349 
perceived risks). Also transition from medical to surgical treatment was not associated by 350 
changes in the expectations of treatment outcomes.  351 
This creates challenges as often; newer surgical techniques have limited information about 352 
safety and efficacy and rarely have long term success data available. This patient perspective 353 
on newer treatments is important when conducting clinical trials for new glaucoma 354 
treatments and when introducing novel procedures into practise.  355 
Limitations  356 
One of the major limitations of this study was homogeneity of the study population as 357 
majority of the patients were Caucasians, above 60 years age and residents of East Midlands, 358 
UK. It is likely that the younger service users may have differing views and experiences that 359 
also warrant investigation.  Articulate, confident and motivated patients were chosen as they 360 
would contribute effectively to focus group discussion. Variable number of patients attended 361 
the focus groups smallest consisted of two participants due to late cancellations but this is 362 
not a major limitation due to adequate number of focus groups conducted in this study [28]. 363 
Facilitators introduced bias was minimised by taking care to adhere to the interview topic 364 
guide [29].   365 
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Conclusion 366 
This is the first qualitative research study to evaluate patients’ perspective of the important 367 
outcomes of glaucoma surgery. While patients understand the relevance of clinical measure 368 
such as IOP control and visual field assessment their perspectives of important glaucoma 369 
treatment outcomes are much more grounded in experience of daily living and maintenance 370 
of quality of life.  Patients are not averse to considering newer surgical options but wished to 371 
have more information regarding long-term outcomes to inform their choice.  372 
Recommendations: 373 
The patients ‘perception of glaucoma surgery outcomes can mould the future glaucoma 374 
consultations with the patients to plan their surgical treatments. With the availability of 375 
various surgical options to manage glaucoma, the treatment plan could be customised for 376 
each patient based on their individual needs to suite their lifestyle requirements. Factors 377 
which could influence the patient’s choices would be their health and fitness at the time of 378 
consultation, their age, sex, social conditions, family and friend support, hobbies, driving 379 
requirements and ability to manage independent living in postoperative period with 380 
minimally induced disability due to the surgery. The patients can be provided with details of 381 
the pathways of different treatments including amount of time spend in the hospital for the 382 
surgery, postoperative follow-ups required, amount of medications, and the visual recovery 383 
expected with each procedure to allow them to make pertinent choices regarding their 384 
treatment. Following the surgery around time of discharge a survey could be conducted to 385 
determine how useful the patients felt this process was to facilitate any modifications 386 
required in future.  387 
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